Open access
Aug 2026
Virtual screening and MD simulation-guided discovery of CDK12-IN-3, a potent ALK inhibitor suppressing neuroblastoma growth in vitro and in vivo
CDK12-IN-3 is validated as a novel selective ALK inhibitor with potent anti-NB activity, providing a promising lead compound and an efficient dynamic simulation-guided drug repurposing paradigm for overcoming ALK inhibitor resistance in high-risk NB.
Tianyi Liu, Xuejiao Hu, Wenxin Yan et al.
· Frontiers in Chemistry · 0 citations